✦ LIBER ✦
Rivastigmine as treatment for patients with mild to moderately severe Alzheimer disease under normal clinical practice conditions. The ENTERPRISE study
✍ Scribed by Cruz Jentoft, A.J.; Hernández, B.
- Book ID
- 121447782
- Publisher
- Elsevier
- Year
- 2014
- Tongue
- English
- Weight
- 665 KB
- Volume
- 29
- Category
- Article
- ISSN
- 2173-5808
No coin nor oath required. For personal study only.